No Data
No Data
Jefferies Maintains ROCHE HOLDINGS AG(RHHVF.US) With Hold Rating
Jefferies analyst Peter Welford maintains $ROCHE HOLDINGS AG(RHHVF.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 52.7% and a total average return of 3.8% over t
Roche's Vabysmo Gets CHMP Recommendation for Third Indication Retinal Vein Occlusion (RVO)
Citi Maintains ROCHE HOLDINGS AG(RHHVF.US) With Buy Rating, Raises Target Price to $375.46
Citi analyst Peter Verdult maintains $ROCHE HOLDINGS AG(RHHVF.US)$ with a buy rating, and maintains the target price at $374.93.According to TipRanks data, the analyst has a success rate of 64.3% and
Roche Launches New Analytical Units for Cobas Pro Integrated Solutions Delivering Greater Efficiency and Capacity to Laboratories
Roche Launches New Highly-sensitive Test to More Easily Diagnose Patients Who May Have B-cell Lymphoma
A Quick Look at Today's Ratings for ROCHE HOLDINGS AG(RHHVF.US), With a Forecast Between $234.18 to $267.64
On Jun 18, major Wall Street analysts update their ratings for $ROCHE HOLDINGS AG(RHHVF.US)$, with price targets ranging from $234.18 to $267.64.Goldman Sachs analyst James Quigley maintains with a se
No Data